Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities.
Saved in:
| Title: | Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities. |
|---|---|
| Authors: | Vaidyanathan J; Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Fletcher EP; Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Ramamoorthy A; Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Madabushi R; Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Burckart GJ; Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2023 Nov; Vol. 63 Suppl 2, pp. S10-S17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-4604 |
|---|---|
| DOI: | 10.1002/jcph.2327 |
